StockWatch
·

FITLIFE BRANDS, INC. Q3 FY26 Results

FTLFQ3 FY26 Results
Filing
MetricValue ($ M)Q2 FY26Q3 FY25
Revenue25.623.5%9.1%
Total Income25.623.5%9.1%
Expenditure22.970.9%8.5%
PBT2.0423.9%16.6%
Net Profit1.5719.5%70.7%
OPM10.36%2.27pp0.49pp
NPM6.13%1.21pp2.21pp
EPS0.1719.1%70.0%
View full financials

FitLife Brands Announces Third Quarter 2026 Results

18 Nov 2026 · 5h ago

Summary

FitLife Brands reported third quarter 2026 revenue of $25.6 million, a 9% increase year-over-year, primarily attributed to the acquisition of Irwin Naturals. Net income saw a substantial 71% rise to $1.6 million, with diluted EPS at $0.16. While total revenue grew, Adjusted EBITDA decreased by 13% to $3.3 million due to restructuring costs. Management noted challenges from a weak consumer environment but expressed encouragement regarding overall revenue stability and cost reduction initiatives.

Key Highlights

  1. 1

    Total revenue for the third quarter of 2026 was $25.6 million, an increase of 9% compared to the third quarter of 2025, driven by the acquisition of Irwin Naturals.

  2. 2

    Wholesale revenue increased by 5% to $13.8 million in the third quarter of 2026 compared to the prior year period.

  3. 3

    Net income for the third quarter of 2026 was $1.6 million, a significant increase of 71% compared to $0.9 million in the same period last year.

  4. 4

    Basic earnings per share were $0.17 and diluted earnings per share were $0.16 for the third quarter of 2026, up from $0.10 and $0.09 respectively in the prior year.

  5. 5

    Adjusted EBITDA for the third quarter of 2026 was $3.3 million, representing a 13% decrease compared to the third quarter of 2025.

  6. 6

    The Company implemented a restructuring initiative during the third quarter of 2026, expected to reduce annual operating expense by approximately $1.2 million.

Management Comments

D

Dayton Judd

Our business continues to be challenged by a weak consumer environment. In addition, we continue to experience challenges unique to some of the categories and channels in which we operate. That said, we have now owned Irwin Naturals for four complete quarters, and we are encouraged that revenue for the Company overall is roughly flat despite the headwinds. In each of the previous four quarters, the Company generated revenue between $25.3 million and $26.5 million and Adjusted EBITDA between $3.3 million and $3.7 million. For the trailing 12 months, revenue is $103.4 million and Adjusted EBITDA is $13.7 million. It is important to note that not all brands are declining. Although a weak consumer environment affects all brands, the only areas where we are seeing notable declines are (1) with MRC on Amazon, and (2) in the specialty retail channel, primarily due to GNC for some of our Legacy FitLife brands and the health food channel for Irwin. Aside from these challenges, we are encouraged by the performance of the rest of the business. Online revenue continues to grow, with the Irwin and MusclePharm brands delivering particularly strong performance and reaching all-time highs during the third quarter of 2026. MusclePharm continues to improve in the wholesale channel as well, achieving its second highest quarter of wholesale revenue during the third quarter of 2026 at substantially improved gross margins. In an effort to operate more efficiently in the current environment, the Company undertook a restructuring initiative during the third quarter. The initiative, which was substantially completed by the end of the third quarter, is anticipated to decrease the Company’s annual operating expense by approximately $1.2 million annually beginning in the fourth quarter of 2026. The Company has also completed other initiatives that are anticipated to result in reduced cost of goods sold. With regard to the balance sheet, our debt increased slightly during the quarter, driven entirely by temporary fluctuations in working capital. More specifically, compared to the end of the second quarter of 2026, accounts receivable increased by $1.1 million, inventory increased by $1.7 million, and prepaids increased by $0.7 million, while accounts payable increased only $0.3 million. We expect working capital to normalize in the future and debt reduction to continue. A substantial portion of the increase in working capital relates to opportunistic, forward purchases or commitment payments for whey protein and fish oil, two commodities that are experiencing dramatic cost increases driven by supply shortages. With payments made during the third quarter (and early in the fourth quarter), the Company has locked in fixed-price supply of fish oil to meet the majority of its needs over approximately the next 12 months. To summarize, we continue to experience headwinds in certain parts of our business, but fortunately not in all. And we believe the cost reduction actions we have recently taken will allow the Company to compete more efficiently going forward.

Informational and educational content only. Not investment advice.